Double the Brain Power

. . . CV Therapeutics (Nasdaq: CVTX) and Pharmacopeia Drug Discovery, Inc. (Nasdaq: PCOP) have entered into a drug discovery and development collaboration with the goal of developing novel therapeutics. The partnership brings together CV's molecular cardiology expertise and Pharmacopeia's cutting-edge drug discovery technology to potentially speed the discovery and development of new therapies for cardiovascular disease.

From: www.SmallcapRecap.com